Targeted Therapy for Drug-Tolerant Persister Cells After Imatinib Treatment for Gastrointestinal Stromal Tumours
Scientists have discovered that this constant attack impacts our overall health and well-being, including the health of our tissues and their aging
The main focus of the GLP1 Companion Program and My Day in the app are still the daily nutrition targets of protein, fruits and veggies, and water, and you can choose to just pay attention to those targets
The absence of IGF-1 elevation and glucose metabolism impairment represents a significant safety advantage for long-term applications
In fact, the drug semaglutide, originally approved under the brand name Ozempic ( for diabetes, was later approved in a higher dosage form as Wegovy ( specifically for the treatment of obesity
The complex reality of peptide analysis What initially drew us to work with GLP-1 RAs was the combination of their exciting therapeutic potential and the complex analytical challenges they present, demanding fit-for-purpose analytical procedures